Table 5 Comparisons of TNF between curcumin supplement and placebo

(a) TNF preexercise

Nicol LM

17

 − 0.5

0

17

 − 0.5

0

Tanabe Y

14

1.83

0.7

14

1.62

0.28

McFarlin BK

14

3.73

0.22

14

3.87

0.37

Basham SA

20

1.17

0.1

20

1.12

0.04

Tanabe Y (pre)

10

0.63

0.18

10

0.63

0.17

Tanabe Y (post)

10

0.59

0.16

10

0.58

0.18

Mallard AR

13

8

5.5

14

5.5

3.7

UMD (95% CI)

0.04 (− 0.00, 0.08)

(b) TNF post-exercise

Nicol LM

17

2.5

2.5

17

2.8

8

Tanabe Y

14

1.55

0.42

14

1.97

1.55

Basham SA

20

1.14

0.1

20

1.09

0.04

Tanabe Y (pre)

10

0.61

0.19

10

0.61

0.19

Tanabe Y (post)

10

0.59

0.11

10

0.62

0.09

Mallard AR

13

7.5

3.4

14

3.4

3.1

UMD (95%CI)

0.01 (− 0.11, 0.13)

(c) TNF at 24 h

Nicol LM

17

1.5

1.4

17

2

4

Tanabe Y

14

1.62

0.35

14

1.83

0.35

McFarlin BK

14

3.58

0.22

14

4.75

0.37

Basham SA

20

0.1

0.1

20

0.96

0.04

Tanabe Y (pre)

10

0.58

0.19

10

0.56

0.14

Tanabe Y (post)

10

0.16

0.54

10

0.55

0.17

Mallard AR

13

8.4

4.1

14

4.1

2.6

UMD (95%CI)

 − 0.40 (− 0.85, 0.06)

(d) TNF at 48 h

Nicol LM

17

3.5

0.5

17

0.8

2.66

Tanabe Y

14

2.04

0.77

14

2.18

1.48

McFarlin BK

14

3.73

0.22

14

4.75

0.37

Basham SA

20

1.08

0.1

20

1.07

0.07

Mallard AR

13

7.2

3.5

14

3.5

1.9

UMD (95%CI)

0.49 (− 0.33, 1.30)

(e) TNF at 72 h

Tanabe Y

14

1.83

0.28

14

1.76

0.28

McFarlin BK

14

3.73

0.22

14

4.6

0.37

Tanabe Y (pre)

10

0.58

0.18

10

0.56

0.15

Tanabe Y (post)

10

0.59

0.13

10

0.58

0.17

Mallard AR

13

7.4

3.5

14

3.5

2.3

UMD (95%CI)

 − 0.08 (− 0.47, 0.31)

(f) TNF at 96 h

Tanabe Y

14

1.83

0.28

14

1.83

0.28

McFarlin BK

14

3.65

0.22

14

4.68

0.44

UMD (95%CI)

 − 0.51 (− 1.52, 0.50)